{"contraindications":{"vaccineGroup":{"contraindication":[{"observationCode":"080","observationTitle":"Adverse reaction to vaccine component","contraindicationText":"Do not vaccinate if the patient has had an adverse reaction to a vaccine component."},{"observationCode":"119","observationTitle":"Severe allergic reaction after previous dose of cholera","contraindicationText":"Do not vaccinate if the patient has had a severe allergic reaction after a previous dose of cholera vaccine."}]}},"series":[{"seriesName":"Cholera 1-dose series","targetDisease":"Cholera","vaccineGroup":"Cholera","seriesAdminGuidance":["The Vaxchora package insert states that CVD 103-HgR should not be given to patients who have received oral or parenteral antibiotics in the preceding 14 days, because antibiotics might have activity against the vaccine strain. ","Non-U.S. vaccines (WC-rBS and BivWC) would count as valid only if there is documentation that a complete series with the appropriate dosing has been given.","No data exist on use of the currently available lyophilized CVD 103-HgR formulation in immunocompromised populations."],"seriesType":"Risk","selectSeries":{"defaultSeries":"No","productPath":"No","seriesGroupName":"Increased Risk","seriesGroup":"1","seriesPriority":"A","seriesPreference":"1","minAgeToStart":"18 years","maxAgeToStart":"65 years"},"indication":[{"observationCode":{"text":"Travel to an area of active cholera transmission","code":"008"},"description":"Administer to adult travelers (aged 18-64 years) from the United States traveling to an area of active cholera transmission.","beginAge":"18 years","endAge":"65 years"}]}]}